iHeartMedia, Inc. to Report Quarterly Financial Results on November 7, 2024

Wendy Goldberg
Chief Communications Officer
(212) 377-1105
WendyGoldberg@iheartmedia.com

Mike McGuinness
EVP, Deputy CFO, and Head of Investor Relations
(212) 915-0607
mbm@iheartmedia.com

iHeartMedia, Inc. (NASDAQ: IHRT) announced today that on Thursday November 7th, 2024, it will issue financial results for the quarter ending September 30, 2024. The company will conduct a conference call at 8:30 a.m. (ET), following the release of its earnings announcement, to discuss its financial results and business outlook.

A live audio webcast of the call will be available on the Investors homepage of iHeartMedia’s website (https://investors.iheartmedia.com/) beginning at 8:30 a.m. (ET) on November 7th. The conference call can also be accessed by dialing (888) 596-4144 (domestic) or +1 646 968-2525 (international) using PIN number 8885116. Please call at least five minutes in advance to ensure that you are connected prior to the call.

An audio replay of the call will be available beginning at 11:30 a.m. (ET) on November 7th in the Events & Presentations section of iHeartMedia’s Investors home page, and at (800) 770-2030 (domestic) or +1 609 800-9909 (international) using PIN number 8885116. The audio replay will be available for a period of thirty days.

The earnings release and any other information related to the call will be accessible on the Investors home page of iHeartMedia’s website.

About iHeartMedia, Inc.

iHeartMedia, Inc. [Nasdaq: IHRT] is the leading audio media company in America, reaching over 250 million people each month. It is number one in both broadcast and digital streaming radio as well as podcasting and audio ad tech, and includes three business segments: The iHeartMedia Multiplatform Group; the iHeartMedia Digital Audio Group; and the Audio and Media Services Group. Visit iHeartMedia.com for more company information.


Read Previous

Global Launch of JETOUR T2 i-DM: Reshapi

Read Next

Nidec Announces Scheduled Commencement o

Add Comment